ECM
TMDX icon

Evergreen Capital Management’s Transmedics TMDX Stock Holding History

Evergreen Capital Management’s Portfolio TMDX Stock Details TMDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-3,540
Closed -$352K – 1663
2026
Q1 		$352K Buy
3,540
+1,184
+50% +$154K 0.01% 1007
2025
Q4 		$287K Sell
2,356
-320
-12% -$40.2K 0.01% 1068
2025
Q3 		$300K Buy
2,676
+415
+18% +$48.6K 0.01% 974
2025
Q2 		$303K Buy
+2,261
New +$248K 0.01% 797

Other funds holding TMDX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $13.8B AUM 163.97% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return

Evergreen Capital Management's TMDX Position: Q2 2026 in Review

Evergreen Capital Management sold out of Transmedics (TMDX) in Q2 2026, closing a stake of 3,540 shares — an estimated $352K sold.

Evergreen Capital Management first reported a position in TMDX in Q2 2025 and held it in 4 quarters. The position peaked at $352K in Q1 2026. 375 funds tracked by Wall St. Rank hold TMDX as of Q2 2026.

  • Evergreen Capital Management reported no remaining Transmedics position as of Q2 2026 after selling out during the quarter.
  • Evergreen Capital Management sold 3,540 Transmedics shares in Q2 2026, an estimated $352K.
  • Evergreen Capital Management first reported a position in Transmedics in Q2 2025 and held it in 4 quarters.
  • Evergreen Capital Management's Transmedics position peaked at $352K in Q1 2026.
  • 375 funds tracked by Wall St. Rank held Transmedics as of Q2 2026.

Based on Evergreen Capital Management's 13F filing for Q2 2026, filed 23 Jul 2026.